Showing results (2541-2550 of 4,138) with videos related to
Sort By:
Pageof 414
Human Gene Therapy|September 12, 2022
Preclinical Evaluation of Foamy Virus Vector-Mediated Gene Addition in Human Hematopoietic Stem/Progenitor Cells for Correction of Leukocyte Adhesion Deficiency Type 1Richard H Smith, Hanan Bloomer, Danielle Fink, et al.Human Gene Therapy|July 29, 1998
Retroviral vector-modified bone marrow stromal cells secrete biologically active factor IX in vitro and transiently deliver therapeutic levels of human factor IX to the plasma of dogs after reinfusionV Cherington, G G Chiang, C A McGrath, et al.Human Gene Therapy|August 7, 1998
Toxicological comparison of E2a-deleted and first-generation adenoviral vectors expressing alpha1-antitrypsin after systemic deliveryW K O'Neal, H Zhou, N Morral, et al.Human Gene Therapy|August 7, 1998
Adenovirus-mediated transfer of human acid maltase gene reduces glycogen accumulation in skeletal muscle of Japanese quail with acid maltase deficiencyS Tsujino, N Kinoshita, T Tashiro, et al.Human Gene Therapy|September 19, 1998
New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenovirusesF J Fallaux, A Bout, I van der Velde, et al.Human Gene Therapy|August 28, 1998
Beta-galactosidase gene transfer to human malignant glioma in vivo using replication-deficient retroviruses and adenovirusesA M Puumalainen, M Vapalahti, R S Agrawal, et al.Human Gene Therapy|July 17, 2012
Gene therapy approaches for lysosomal storage disease: next-generation treatmentBarry J Byrne, Darin J Falk, Nathalie Clément, et al.Human Gene Therapy|September 15, 2012
Center for fetal monkey gene transfer for heart, lung, and blood diseases: an NHLBI resource for the gene therapy communityAlice F Tarantal, Sonia I SkarlatosHuman Gene Therapy|August 1, 2012
Repeated lentivirus-mediated granulocyte colony-stimulating factor administration to treat canine cyclic neutropeniaOfer Yanay, David C Dale, William R A OsborneHuman Gene Therapy|August 15, 2012
Capsid-modified adenoviral vectors for improved muscle-directed gene therapyKilian Guse, Masataka Suzuki, Gautam Sule, et al.Pageof 414